Literature DB >> 15496980

Rapid amplification of immunoglobulin heavy chain switch (IGHS) translocation breakpoints using long-distance inverse PCR.

T Sonoki1, T G Willis, D G Oscier, E L Karran, R Siebert, M J S Dyer.   

Abstract

Molecular cloning of immunoglobulin heavy chain (IGH) translocation breakpoints identifies genes of biological importance in the development of normal and malignant B cells. Long-distance inverse PCR (LDI-PCR) was first applied to amplification of IGH gene translocations targeted to the joining (IGHJ) regions. We report here successful amplification of the breakpoint of IGH translocations targeted to switch (IGHS) regions by LDI-PCR. To detect IGHS translocations, Southern blot assays using 5' and 3' switch probes were performed. Illegitimate Smu rearrangements were amplified from the 5' end (5'Smu LDI-PCR) from the alternative derivative chromosome, and those of Sgamma or Salpha were amplified from the 3' end (3'Sgamma or 3'alpha LDI-PCR) from the derivative chromosome 14. Using a combination of these methods, we have succeeded in amplifying IGHS translocation breakpoints involving FGFR3/MMSET on 4p16, BCL6 on 3q27, MYC on 8q24, IRTA1 on 1q21 and PAX5 on 9p13 as well as BCL11A on 2p13 and CCND3 on 6p21. The combination of LDI-PCR for IGHJ and IGHS allows rapid molecular cloning of almost all IGH gene translocation breakpoints.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15496980     DOI: 10.1038/sj.leu.2403500

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


  9 in total

1.  Demonstration of array-based analysis for highly multiplexed PCR assays application to detection of IGH@-BCL2 translocations in FFPE follicular lymphoma specimens.

Authors:  Janice M Spence; Paul G Rothberg; Nancy Wang; W Richard Burack
Journal:  J Mol Diagn       Date:  2011-05       Impact factor: 5.568

2.  Molecular cytogenetic characterization of t(14;19)(q32;p13), a new recurrent translocation in B cell malignancies.

Authors:  Francesca Micci; Ioannis Panagopoulos; Geir E Tjønnfjord; Arne Kolstad; Jan Delabie; Klaus Beiske; Sverre Heim
Journal:  Virchows Arch       Date:  2007-04-04       Impact factor: 4.064

3.  t(X;14)(p11;q32) in MALT lymphoma involving GPR34 reveals a role for GPR34 in tumor cell growth.

Authors:  Stephen M Ansell; Takashi Akasaka; Ellen McPhail; Michelle Manske; Esteban Braggio; Tammy Price-Troska; Steven Ziesmer; Frank Secreto; Rafael Fonseca; Mamta Gupta; Mark Law; Thomas E Witzig; Martin J S Dyer; Ahmet Dogan; James R Cerhan; Anne J Novak
Journal:  Blood       Date:  2012-09-10       Impact factor: 22.113

4.  Identification of the gene encoding cyclin E1 (CCNE1) as a novel IGH translocation partner in t(14;19)(q32;q12) in diffuse large B-cell lymphoma.

Authors:  Inga Nagel; Takashi Akasaka; Wolfram Klapper; Stefan Gesk; Sebastian Böttcher; Matthias Ritgen; Lana Harder; Michael Kneba; Martin J S Dyer; Reiner Siebert
Journal:  Haematologica       Date:  2009-05-19       Impact factor: 9.941

5.  Molecular and genomic aberrations in Chlamydophila psittaci negative ocular adnexal marginal zone lymphomas.

Authors:  Daxing Zhu; Offiong F Ikpatt; Sander R Dubovy; Chen Lossos; Yasodha Natkunam; Jennifer R Chapman-Fredricks; Yao-Shan Fan; Izidore S Lossos
Journal:  Am J Hematol       Date:  2013-07-23       Impact factor: 10.047

6.  Aberrant immunoglobulin class switch recombination and switch translocations in activated B cell-like diffuse large B cell lymphoma.

Authors:  Georg Lenz; Inga Nagel; Reiner Siebert; Anna V Roschke; Warren Sanger; George W Wright; Sandeep S Dave; Bruce Tan; Hong Zhao; Andreas Rosenwald; Hans Konrad Muller-Hermelink; Randy D Gascoyne; Elias Campo; Elaine S Jaffe; Erlend B Smeland; Richard I Fisher; W Michael Kuehl; Wing C Chan; Louis M Staudt
Journal:  J Exp Med       Date:  2007-03-12       Impact factor: 14.307

7.  Generation and characteristics of a novel "double-hit" high grade B-cell lymphoma cell line DH-My6 with MYC/IGH and BCL6/IGH gene arrangements and potential molecular targeted therapies.

Authors:  Hiroaki Kikuchi; Tomonori Higuchi; Yumiko Hashida; Ayuko Taniguchi; Mikio Kamioka; Takahiro Taguchi; Akihito Yokoyama; Ichiro Murakami; Mikiya Fujieda; Masanori Daibata
Journal:  Oncotarget       Date:  2018-09-11

8.  t(9;14)(p13;q32)/PAX5-IGH translocation as a secondary cytogenetic abnormality in diffuse large B-cell lymphoma.

Authors:  Hitoshi Ohno; Kayo Takeoka; Chiyuki Kishimori; Miho Nakagawa; Katsuhiro Fukutsuka; Fumiyo Maekawa; Masahiko Hayashida; Takashi Akasaka; Shinji Sumiyoshi
Journal:  J Clin Exp Hematop       Date:  2021-10-26

9.  Inactivation of BANK1 in a novel IGH-associated translocation t(4;14)(q24;q32) suggests a tumor suppressor role in B-cell lymphoma.

Authors:  J Yan; K Nie; S Mathew; Y Tam; S Cheng; D M Knowles; A Orazi; W Tam
Journal:  Blood Cancer J       Date:  2014-05-30       Impact factor: 11.037

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.